The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study.
Israel ManzanedoF PereiraÁ SerranoE Pérez-ViejoB Martínez-TorresL CarriónJ CalzasPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2019)
The cytostatic used in HIPEC did not have a negative effect in the prognosis of patients with advanced ovarian cancer.